Physician profile
Arthur P Topoulos
NPI 1952331944
$36,144.36
in general payments reported to CMS, 2019-2025
28 companies · $1,351 in 2025
The $1,351 reported for 2025 was more than what 80% of Nuclear Cardiology providers received nationally (typical 2025 total: $434).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $146 · 2021: $1,591 · 2022: $1,375 · 2023: $1,965 · 2024: $2,911 · 2025: $1,351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,252 · Long Term Medical Supply Or Device Loan: $648 · Travel and Lodging: $327.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,252.32 |
| Long Term Medical Supply Or Device Loan | $648.00 |
| Travel and Lodging | $326.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $24,862.13 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $2,042.50 | 2019-2025 | Venclose Maven Catheter, Rotarexs 6 F X 135 Cm |
| Inari Medical, INC. | $1,301.18 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $1,215.11 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin |
| Cook Medical LLC | $1,183.78 | 2019-2025 | Zilver Ptx, Rosen, Cook |
| Silk Road Medical, INC. | $1,167.97 | 2019-2021 | |
| Veryan Medical Incorporated | $821.41 | 2022-2024 | Biomimics 3d Vascular Stent System |
| Cashflow Solutions, LLC | $661.13 | 2024-2025 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Surmodics, INC. | $624.33 | 2022-2024 | Prowl, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Philips North America LLC | $551.71 | 2019-2024 | (Br5) Peripheral Ivus |
| Shockwave Medical, INC | $381.09 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $308.39 | 2021-2025 | Symplicity G3, Cobalt Dr Mri Surescan, Onyx Frontier |
| Abbott Laboratories | $160.12 | 2021 | |
| Cordis US Corp. | $127.79 | 2023-2024 | Mynx Control, Brite Tip Radianz, Mynxgrip |
| Siemens Medical Solutions USA, INC. | $110.76 | 2024 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocompatibles, INC. | $110.18 | 2019 | |
| Edwards Lifesciences Corporation | $108.85 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boston Scientific Corporation | $89.11 | 2021-2025 | Varithena Administration Pack |
| Imperative Care, INC | $63.62 | 2024 | Symphony Catheter |
| Atricure, INC. | $57.70 | 2025 | Epi-Ease Epicardial Access System, Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Janssen Scientific Affairs, LLC | $53.42 | 2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.84 | 2023-2025 | Lifevest |
| Becton, Dickinson and Company | $30.77 | 2024 | Rotarexs 6 F X 135 Cm |
| Inspire Medical Systems, INC. | $28.28 | 2023 | Inspire |
| Cardiva Medical, INC. | $24.67 | 2021 | |
| Cardiovascular Systems INC. | $23.52 | 2022 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Topoulos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.